Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Prawira · SciRah

Researcher profile · Semantic Scholar

A. Prawira

Share profile

A. Prawira — researcher profile on SciRah

h-index: 10
Works: 26
Citations: 750

Most-cited papers

Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer
J. Mehnert, A. Varga, M. Brose, R. Aggarwal +11 more
2019BMC Cancer173 citations Open access
Semantic Scholar
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies
P. Schöffski, D. Tan, Miguel Martín, M. Ochoa de Olza +28 more
2022Journal for ImmunoTherapy of Cancer147 citations Open access
Semantic Scholar
Systemic therapies for recurrent or metastatic nasopharyngeal carcinoma: a systematic review
A. Prawira, S. Oosting, T.-W. Chen, K. Delos Santos +5 more
2017British Journal of Cancer100 citations Open access
Semantic Scholar
Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies.
D. Hong, P. Schöffski, A. Calvo, J. Sarantopoulos +16 more
201865 citations
Semantic Scholar
Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1b KEYNOTE-028 study.
J. Mehnert, A. Varga, M. Brose, R. Aggarwal +11 more
201652 citations
Semantic Scholar
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study
M. Oliva, D. Chepeha, D. Araujo, J. Díaz-Mejía +28 more
2021Journal for ImmunoTherapy of Cancer49 citations Open access
Semantic Scholar
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration-Resistant Prostate Cancer (mCRPC).
A. Hansen, I. Tannock, A. Templeton, E. Chen +9 more
2019The Oncologist43 citations Open access
Semantic Scholar
Phase I trial of alpelisib in combination with concurrent cisplatin-based chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck.
Daphne Day, A. Prawira, A. Spreafico, J. Waldron +13 more
2020Oral Oncology39 citations
Semantic Scholar
Data resources for the identification and interpretation of actionable mutations by clinicians
A. Prawira, Trevor J Pugh, T. Stockley, L. Siu
2017Annals of Oncology20 citations Open access
Semantic Scholar
Phase 1 results of PTC596, a novel small molecule targeting cancer stem cells (CSCs) by reducing levels of BMI1 protein.
J. Infante, P. Bedard, G. Shapiro, T. Bauer +7 more
201716 citations
Semantic Scholar
Phase I trial of dacomitinib, a pan-human epidermal growth factor receptor (HER) inhibitor, with concurrent radiotherapy and cisplatin in patients with locoregionally advanced squamous cell carcinoma of the head and neck (XDC-001)
A. Prawira, Irene Braña-García, A. Spreafico, A. Hope +13 more
2016Investigational new drugs10 citations
Semantic Scholar
SNOW: Sitravatinib and nivolumab in oral cavity cancer (OCC) window of opportunity study.
Marc Oliva Bernal, D. Araujo, D. Chepeha, A. Prawira +16 more
20208 citations
Semantic Scholar
Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the GEMS‐001 clinical trial
A. Hernando-Calvo, E. Malone, Daphne Day, A. Prawira +10 more
2023Cancer Medicine7 citations Open access
Semantic Scholar
Development of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs) in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN)
A. Prawira, P. Dufort, J. Halankar, D. Paravasthu +7 more
20166 citations Open access
Semantic Scholar
Abstract PS12-12: Efficacy and safety of AB928 plus pegylated liposomal doxorubicin (PLD) with or without IPI-549 in participants with metastatic ovarian and triple negative breast cancer
J. Sachdev, A. Prawira, A. Chaudhry, V. Ganju +6 more
20213 citations
Semantic Scholar
Abstract P154: Genomic profiling and matched therapy for recurrent or metastatic salivary gland neoplasms. Results from the matched cohort of the GEMS-001 clinical trial
A. Hernando-Calvo, E. Malone, D. Dai, A. Prawira +8 more
2021Poster Presentations - Proffered Abstracts3 citations
Semantic Scholar
Abstract CT124: Sitravatinib and nivolumab in oral cavity cancer window of opportunity study (SNOW)
M. O. Bernal, D. Chepeha, A. Prawira, D. Vines +16 more
2019Clinical Trials3 citations
Semantic Scholar
384 A Phase 1 study to evaluate the safety, PK, and antitumor activity of AK117, an anti-CD47 monoclonal antibody, in subjects with relapsed/refractory advanced or metastatic solid tumors or lymphomas
A. Prawira, J. Coward, A. Mislang, A. Nagrial +7 more
20202 citations Open access
Semantic Scholar
A phase I dose escalation and dose expansion study of the anti-programmed cell death-1 (PD-1) antibody AK105.
D. Kotasek, J. Coward, P. de Souza, C. Underhill +4 more
2019Journal of Clinical Oncology2 citations
Semantic Scholar
A signal-seeking trial of olaparib and durvalumab in homologous repair-deficient tumors: A sub-study of the cancer molecular screening and therapeutics (MoST) program.
A. Joshua, A. Prawira, S. Thavaneswaran, R. Cosman +15 more
20201 citations
Semantic Scholar
Giant Prolactinoma Presenting As a Base of Skull Tumor With Nasopharyngeal Extension: A Potential Diagnostic Pitfall in Neuroendocrine Lesions of the Base of Skull
A. Prawira, D. Lazinski, L. Siu, B. Perez-Ordonez
2017Head and Neck Pathology1 citations Open access
Semantic Scholar
1468PDevelopment of a web-based application using machine learning algorithms to facilitate systematic literature reviews
Hon Wong, T. Luechtefeld, A. Prawira, Z. Patterson +13 more
20171 citations Open access
Semantic Scholar
Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): A phase II trial in men with metastatic castrate resistant prostate cancer (mCRPC)
A. Hansen, I. Tannock, A. Templeton, A. Prawira +10 more
20161 citations Open access
Semantic Scholar
115PEvaluation of a predictive radiomics signature for response to immune checkpoint inhibitors (ICIs)
A. Prawira, A. Stundzia, P. Dufort, J. Halankar +15 more
20170 citations Open access
Semantic Scholar
Pantoprazole affecting docetaxel resistance pathways via autophagy (PANDORA): a phase II trial in men with castration resistant prostate cancer (mCRPC).
A. Hansen, I. Tannock, A. Prawira, J. Knox +10 more
20160 citations
Semantic Scholar
Systemic therapies for recurrent/metastatic nasopharyngeal carcinoma (RM NPC).
A. Prawira, S. Oosting, T. Chen, R. Saluja +5 more
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Hansen×11
Invite
A. Hansen — researcher profile on SciRah
A. Spreafico×8
Invite
A. Spreafico — researcher profile on SciRah
L. Siu×8
Invite
L. Siu — researcher profile on SciRah
I. Weinreb×7
Invite
I. Weinreb — researcher profile on SciRah

×6

Invite

L. Siu — researcher profile on SciRah

B. Perez-Ordonez×5

Invite

B. Perez-Ordonez — researcher profile on SciRah

Invite

E. Chen — researcher profile on SciRah

Invite

Lisa Wang — researcher profile on SciRah

Invite

F. De Braud — researcher profile on SciRah

Invite

A. Hansen — researcher profile on SciRah

Invite

S. Bratman — researcher profile on SciRah

Invite

A. Joshua — researcher profile on SciRah